Literature DB >> 15985779

[Does dark field microscopy according to Enderlein allow for cancer diagnosis? A prospective study].

Samer El-Safadi1, Hans-Rudolf Tinneberg, Richard von Georgi, Karsten Münstedt, Friede Brück.   

Abstract

BACKGROUND: Dark field microscopy according to Enderlin claims to be able to detect forthcoming or beginning cancer at an early stage through minute abnormalities in the blood. In Germany and the USA, this method is used by an increasing number of physicians and health practitioners (non-medically qualified complementary practitioners), because this easy test seems to give important information about patients' health status.
OBJECTIVE: Can dark field microscopy reliably detect cancer?
MATERIALS AND METHODS: In the course of a prospective study on iridology, blood samples were drawn for dark field microscopy in 110 patients. A health practitioner with several years of training in the field carried out the examination without prior information about the patients.
RESULTS: Out of 12 patients with present tumor metastasis as confirmed by radiological methods (CT, MRI or ultra-sound) 3 were correctly identified. Analysis of sensitivity (0.25), specificity (0.64), positive (0.09) and negative (0.85) predictive values revealed unsatisfactory results.
CONCLUSION: Dark field micoroscopy does not seem to reliably detect the presence of cancer. Clinical use of the method can therefore not be recommended until future studies are conducted.

Entities:  

Mesh:

Year:  2005        PMID: 15985779     DOI: 10.1159/000085212

Source DB:  PubMed          Journal:  Forsch Komplementarmed Klass Naturheilkd        ISSN: 1424-7364


  2 in total

1.  Education of non-medical practitioners in Germany-an analysis of course subjects of specialized schools.

Authors:  Lea Hoffmeister; Jutta Huebner; Christian Keinki; Karsten Muenstedt
Journal:  Wien Med Wochenschr       Date:  2021-12-13

2.  Pleomorphic bacteria-like structures in human blood represent non-living membrane vesicles and protein particles.

Authors:  Jan Martel; Cheng-Yeu Wu; Pei-Rong Huang; Wei-Yun Cheng; John D Young
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.